Showing results (31-40 of 52) with videos related to
Sort By:
Pageof 6
Clinical Breast Cancer|August 31, 2021
Characterizing Occult Nodal Disease Within a Clinically Node-Negative, Neoadjuvant Breast Cancer PopulationJacob B Hammond, Derek W Scott, Heidi E Kosiorek, et al.Breast Cancer Research : BCR|July 13, 2018
The association of genomic lesions and PD-1/PD-L1 expression in resected triple-negative breast cancersMichael T Barrett, Elizabeth Lenkiewicz, Smriti Malasi, et al.Journal of the National Cancer Institute|December 6, 2011
Predictability of adjuvant trastuzumab benefit in N9831 patients using the ASCO/CAP HER2-positivity criteriaEdith A Perez, Amylou C Dueck, Ann E McCullough, et al.Oncotarget|August 29, 2015
Genomic amplification of 9p24.1 targeting JAK2, PD-L1, and PD-L2 is enriched in high-risk triple negative breast cancerMichael T Barrett, Karen S Anderson, Elizabeth Lenkiewicz, et al.American Journal of Surgery|November 26, 2015
Regional recurrence in the era of sentinel lymph node biopsyMaria E Linnaus, Amylou C Dueck, Heidi E Kosiorek, et al.Breast Cancer Research and Treatment|January 8, 2014
Central pathology laboratory review of HER2 and ER in early breast cancer: an ALTTO trial [BIG 2-06/NCCTG N063D (Alliance)] ring studyAnn E McCullough, Patrizia Dell'orto, Monica M Reinholz, et al.Breast Cancer Research and Treatment|March 13, 2013
RC0639: phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast cancerAlvaro Moreno-Aspitia, Amylou C Dueck, Ismael Ghanem-Cañete, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 8, 2013
Impact of PTEN protein expression on benefit from adjuvant trastuzumab in early-stage human epidermal growth factor receptor 2-positive breast cancer in the North Central Cancer Treatment Group N9831 trialEdith A Perez, Amylou C Dueck, Ann E McCullough, et al.Plos One|December 11, 2012
Deep clonal profiling of formalin fixed paraffin embedded clinical samplesTara Holley, Elizabeth Lenkiewicz, Lisa Evers, et al.Annals of Surgical Oncology|September 19, 2013
Androgen receptor-positive triple negative breast cancer: a unique breast cancer subtypeLee J McGhan, Ann E McCullough, Cheryl A Protheroe, et al.Pageof 6